CHARLTON RALPH WILLIAM III

PrivateCIK: 1919397
Location

DALY CITY, CA

CHARLTON RALPH WILLIAM III (Chief Medical Officer) exercised options at SPRUCE BIOSCIENCES, INC.

Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.

M · 3 exercises
InsiderCHARLTON RALPH WILLIAM IIICIK 1919397
IssuerSPRUCE BIOSCIENCES, INC.CIK 1683553
Officer· Chief Medical Officer
Since Mar 2022
-58.78K
Net shares
Net seller
$28.5K
Total sold
0
Open market trades
0B · 0S
9
Total transactions
164.75K acquired · 223.53K disposed
Non-Derivative Transactions6

Common Stock

Direct
M · Option Exercise

Shares

+106.40K

Price / share

Trade value

% of position

192.2%
12/10/2024
55.37K161.77K

Common Stock

Direct
F · Tax Withholding

Shares

37.96K

Price / share

$0.54

Trade value

$20.39K

% of position

23.5%
12/10/2024
161.77K123.81K

Common Stock

Direct
M · Option Exercise

Shares

+26.60K

Price / share

Trade value

% of position

21.5%
12/16/2024
123.81K150.41K

Common Stock

Direct
F · Tax Withholding

Shares

9.49K

Price / share

$0.39

Trade value

$3.69K

% of position

6.3%
12/16/2024
150.41K140.92K

Common Stock

Direct
M · Option Exercise

Shares

+31.75K

Price / share

Trade value

% of position

22.5%
12/16/2024
140.92K172.67K

Common Stock

Direct
F · Tax Withholding

Shares

11.33K

Price / share

$0.39

Trade value

$4.40K

% of position

6.6%
12/16/2024
172.67K161.34K
Total

Net shares

+105.97K

Net value

-$28.48K

Derivative Transactions3

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

106.40K shares

Shares

106.40K

Strike price

0

Held after

106.40K

Exercisable

12/10/2024

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

26.60K shares

Shares

26.60K

Strike price

0

Held after

79.80K

Exercisable

12/16/2024

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

31.75K shares

Shares

31.75K

Strike price

0

Held after

63.50K

Exercisable

12/16/2024
CHARLTON RALPH WILLIAM III — Insider Transaction (Form 4) Filed Dec 20, 2024 | Finecho